Equipoise 200

£34.00

Category:

Boldenone Undecylenate (Equipoise)

Drug Class: Anabolic-Androgenic Steroid (AAS)
Type: Injectable
Common Brand Names: Equipoise, Ganabol, Ultragan
Use (Clinical / Recreational):

  • Clinical: Previously used in veterinary medicine to treat horses
  • Recreational: Used for lean muscle gain, endurance, and appetite stimulation

Half-Life: ~14 days
Administration: Intramuscular injection, 1–2x weekly
Typical Recreational Dose: 300–600mg/week
Cycle Duration: 12–16 weeks (due to long half-life)

Primary Benefits:

  • Steady, lean muscle gains
  • Increases appetite (varies by user)
  • Enhances red blood cell production and endurance
  • Minimal water retention

Common Side Effects:

  • Acne and oily skin
  • Increased hair shedding (in androgen-sensitive users)
  • Mild water retention at higher doses
  • Raised blood pressure

Serious Risks:

  • Suppresses natural testosterone production
  • Thickens blood (↑ RBC and haematocrit) – increased clot risk
  • May negatively affect cholesterol (↓ HDL, ↑ LDL)
  • Long detection time (up to 5 months) – not suitable for tested athletes

Mitigation / Harm Reduction Tips:

  • Monitor haematocrit and donate blood if elevated
  • Keep dosage moderate to reduce cardiovascular strain
  • Run regular bloods: RBC, lipids, liver function, hormone panel
  • Always stack with testosterone to avoid libido and mood suppression
  • Not ideal for cutting phases due to possible appetite stimulation

Stacking Considerations:

  • Often used with Test E or C for lean bulking
  • Avoid with other RBC-raising compounds (e.g. Tren) unless well-monitored
  • Can be paired with orals (e.g. Turinabol) for synergy

PCT Needs:

  • Required unless on TRT
  • Begin 3 weeks after last injection due to long half-life
  • Typical protocol:
    • Nolvadex 40/40/20/20
    • Clomid 50/50/25/25
    • Consider extending PCT if cycle length was >14 weeks

Reviews

There are no reviews yet.

Be the first to review “Equipoise 200”

Your email address will not be published. Required fields are marked *

Scroll to Top